Parkinson’s Disease is a progressive nervous system disorder that affects movement. Certain nerve cells called neurons in the brain gradually break down or die.
Many of the symptoms are due to a loss of neurons that produce a chemical in the brain called dopamine. When dopamine levels decrease, it causes abnormal brain activity, leading to impaired movement and other symptoms such as thinking difficulties, depression/emotional changes, swallowing problems, chewing and eating problems, sleeping issues, bladder control, and constipation to name a few.
Symptoms start gradually, perhaps just a tremor to just one hand, but the disorder progresses causing stiffness or slowing of movement. Sadly, there is no cure for Parkinson’s Disease.
Palliative Care vs Hospice Care for Parkinson’s Disease
Parkinson’s disease is managed differently in palliative care versus hospice care because the goals of care diverge as the illness progresses. In palliative care, treatment is focused on optimizing quality of life while patients may still be pursuing disease-directed therapies. Management emphasizes the monitoring of symptoms and sequale of disease and medications, making recommendations in care and working closely and collaboratively with patient and loved ones, as well as patient’s medical team and specialists.
Palliative teams also address non-motor symptoms—depression, anxiety, sleep disturbance, constipation, and autonomic dysfunction—alongside physical, occupational, and speech therapies to preserve function and independence.
Our Palliative Care Team works collaboratively on a holistic level, focusing on supportive care while optimizing quality of life along with symptom management.
In hospice care, the treatment approach shifts away from disease modification and symptom optimization toward comfort-focused care in the context of limited life expectancy. Parkinson’s medications are often simplified rather than aggressively adjusted, with the goal of reducing pill burden and adverse effects while maintaining basic comfort and mobility. Interventions such as deep brain stimulation management, frequent medication titration, or hospital-based therapies are typically discontinued. Greater emphasis is placed on managing advanced symptoms such as pain, dyspnea, dysphagia, rigidity, and terminal agitation, often using comfort medications that may not be part of standard Parkinson’s regimens.
Another key difference lies in the scope of psychosocial and caregiver support. Palliative care integrates advance care planning early, helping patients and families prepare for future decisions around feeding tubes, aspiration risk, and cognitive decline, while still supporting longer-term living with the disease. Hospice care, by contrast, intensifies emotional, spiritual, and caregiver support as the end of life approaches, providing 24/7 access to clinical guidance and bereavement services. While both models prioritize dignity and symptom relief, hospice care centers on comfort in the final phase of Parkinson’s disease, whereas palliative care supports patients across a broader span of the illness trajectory.
. . . .